"Thyroid Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the THYROID GLAND.
Descriptor ID |
D013964
|
MeSH Number(s) |
C04.588.322.894 C04.588.443.915 C19.344.894 C19.874.788
|
Concept/Terms |
Thyroid Neoplasms- Thyroid Neoplasms
- Neoplasm, Thyroid
- Thyroid Neoplasm
- Neoplasms, Thyroid
Thyroid Carcinoma- Thyroid Carcinoma
- Carcinoma, Thyroid
- Carcinomas, Thyroid
- Thyroid Carcinomas
- Cancer of Thyroid
- Thyroid Cancers
- Thyroid Cancer
- Cancer, Thyroid
- Cancers, Thyroid
- Cancer of the Thyroid
Thyroid Adenoma- Thyroid Adenoma
- Adenoma, Thyroid
- Adenomas, Thyroid
- Thyroid Adenomas
|
Below are MeSH descriptors whose meaning is more general than "Thyroid Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Thyroid Neoplasms".
This graph shows the total number of publications written about "Thyroid Neoplasms" by people in this website by year, and whether "Thyroid Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 2 | 1 | 3 |
1995 | 9 | 7 | 16 |
1996 | 8 | 5 | 13 |
1997 | 7 | 3 | 10 |
1998 | 6 | 3 | 9 |
1999 | 11 | 0 | 11 |
2000 | 13 | 1 | 14 |
2001 | 13 | 1 | 14 |
2002 | 6 | 2 | 8 |
2003 | 18 | 0 | 18 |
2004 | 19 | 2 | 21 |
2005 | 26 | 3 | 29 |
2006 | 19 | 1 | 20 |
2007 | 28 | 3 | 31 |
2008 | 26 | 3 | 29 |
2009 | 31 | 1 | 32 |
2010 | 25 | 3 | 28 |
2011 | 22 | 7 | 29 |
2012 | 26 | 3 | 29 |
2013 | 35 | 4 | 39 |
2014 | 34 | 4 | 38 |
2015 | 39 | 6 | 45 |
2016 | 39 | 4 | 43 |
2017 | 39 | 2 | 41 |
2018 | 31 | 3 | 34 |
2019 | 28 | 3 | 31 |
2020 | 22 | 6 | 28 |
2021 | 24 | 0 | 24 |
2022 | 24 | 0 | 24 |
2023 | 20 | 0 | 20 |
2024 | 26 | 1 | 27 |
To return to the timeline,
click here.
Below are the most recent publications written about "Thyroid Neoplasms" by people in Profiles.
-
Management of pediatric thyroid carcinoma. Curr Opin Otolaryngol Head Neck Surg. 2024 Dec 01; 32(6):438-443.
-
Combination Targeted Therapy with Pembrolizumab and Lenvatinib in Progressive, Radioiodine-Refractory Differentiated Thyroid Cancers. Clin Cancer Res. 2024 Sep 03; 30(17):3757-3767.
-
Initial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer: The FAST Multidisciplinary Group Consensus Statement. JAMA Oncol. 2024 Sep 01; 10(9):1264-1271.
-
Analytical Validation of a Telomerase Reverse Transcriptase (TERT) Promoter Mutation Assay. J Clin Endocrinol Metab. 2024 Aug 13; 109(9):2269-2273.
-
Pediatric Medullary Thyroid Carcinoma: Clinical Presentations and Long-Term Outcomes in 144 Patients Over 6 Decades. J Clin Endocrinol Metab. 2024 Aug 13; 109(9):2256-2268.
-
Durability of Response With Selpercatinib in Patients With RET-Activated Thyroid Cancer: Long-Term Safety and Efficacy From LIBRETTO-001. J Clin Oncol. 2024 Sep 20; 42(27):3187-3195.
-
Exploring markers of immunoresponsiveness in papillary thyroid carcinoma and future treatment strategies. J Immunother Cancer. 2024 Jul 29; 12(7).
-
The Multi-Institutional Medullary Thyroid Cancer Collaborative Registry: Can a Rare Tumor Registry Accurately Represent the Real-World Patient Population? Thyroid. 2024 Sep; 34(9):1117-1125.
-
Erectile Dysfunction in Patients Treated with Selpercatinib for RET-Altered Thyroid Cancer. Thyroid. 2024 Sep; 34(9):1177-1180.
-
Efficacy and safety of NTRK inhibitors in patients with NTRK fusion-positive lung and thyroid cancers. Clin Adv Hematol Oncol. 2024 Jul-Aug; 22 Suppl 5(6):1-20.